Related content

Effect of entacapone on plasma homocysteine levels in Parkinson’s disease patients

By Nevrly Martin   Kanovsky Petr   Vranova Hana   Langova Katerina   Hlustik Petr  

Neurological Sciences, Vol. 31, Iss. 5, 2010-10 ,pp. : 565-569

Springer Publishing Company

Access to resources Recommend Favorite

Aberrant sexual behaviours in Parkinson’s disease during dopaminergic treatment

By Cannas Antonino   Solla Paolo   Floris Gian   Serra Giulia   Tacconi Paolo   Marrosu Maria  

Journal of Neurology, Vol. 254, Iss. 1, 2007-01 ,pp. : 110-112

Springer Publishing Company

Access to resources Recommend Favorite

Gait variability in Parkinson’s disease: influence of walking speed and dopaminergic treatment

By Bryant Mon S   Rintala Diana H   Hou Jyhgong G   Charness Ann L   Fernandez Angel L   Collins Robert L   Baker Jeff   Lai Eugene C   Protas Elizabeth J  

Neurological Research, Vol. 33, Iss. 9, 2011-11 ,pp. : 959-964

Maney Publishing

Access to resources Recommend Favorite

Nocturnal hypertension and dysautonomia in patients with Parkinson’s disease: are they related?

By Berganzo Koldo   Díez-Arrola Begoña   Tijero Beatriz   Somme Johanne   Lezcano Elena   Llorens Verónica   Ugarriza Iratxe   Ciordia Roberto   Gómez-Esteban J.   Zarranz Juan  

Journal of Neurology, Vol. 260, Iss. 7, 2013-07 ,pp. : 1752-1756

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence and treatment strategies of dyskinesia in patients with Parkinson’s disease

By Müller T.   Woitalla D.   Russ H.   Hock K.   Haeger D. A.  

Journal of Neural Transmission, Vol. 114, Iss. 8, 2007-08 ,pp. : 1023-1026

Springer Publishing Company

Access to resources Recommend Favorite